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Abstract
Objectives Recent preliminary evidence suggests that mindfulness-based programmes may be beneficial in the treatment of
patients suffering from current depression. Due to the heterogeneity of patients with this diagnosis, a specialisation in treatment
concepts for subgroups of patients may be beneficial.
Methods This randomised controlled pilot study investigated the effectiveness of an eight-week mindfulness-based day hospital
treatment for patients with current depression and work-related conflicts (MDT-DH) under naturalistic conditions. Eighty-one
currently depressed patients with work-related conflicts were randomly assigned to either MDT-DH (including personalised
psychopharmacological treatment if necessary) or a waitlist condition including a psychopharmacological consultation (PCC).
Outcomes were assessed at post-treatment and at 8-month follow-up. The primary outcome was depression severity (Beck
Depression Inventory) at post-treatment. Secondary outcomes were work ability (Work Ability Index) and mindfulness
(Kentucky Inventory of Mindfulness Skills).
Results A multilevel analysis revealed that compared with patients in PCC, patients in the MDT-DH group showed a greater
reduction in depression severity, higher work ability and heightened levels of mindfulness after 8 weeks than patients in the PCC
group. These improvements were stable during the 8-month follow-up period.
Conclusions Findings of the present pilot study suggest that a treatment concept involving intensive training in mindfulness can
be successfully established in a day hospital and leads to clinically meaningful reductions in depression severity and increases in
work ability in patients suffering from current depression. The generalisability of the findings may be limited due to small sample
size, selective patient group and study design.
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Major depression is a common mental disorder and one of the
leading causes of disability worldwide (World Health
Organization 2017). There is pronounced heterogeneity in pa-
tients with a diagnosis of depression (Ferrari et al. 2013) and it
is well known that work-related psychosocial factors can play
a major role in the development and maintenance of chronic
stress, impaired functioning and depression (Bonde 2008;
Melchior et al. 2007; Netterstrøm et al. 2008; Siegrist 2008).
A systematic review including a meta-analysis found moder-
ately strong evidence for lack of decision latitude, job strain
(i.e. high psychological demands and low decision latitude)
and bullying to be related to depressive symptoms (Theorell
et al. 2015). Further limited evidence was found for low sup-
port, effort reward imbalance, unfavourable social climate,
conflicts with superiors and colleagues, job insecurity and
long working week (Theorell et al. 2015). High job strain is
also associated with an inability to ‘unwind’ physiologically
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after work and increased rumination (Cropley and Millward
Purvis 2003). Against the background of these stressors,
preventing over-engagement with work, learning to let go
(e.g., of problems, conflicts or perfectionism) and increasing
awareness of one’s organismic states and needs (e.g., tired-
ness, hunger or thirst) and current stress level seem to be
important in coping with work-related stressors and resulting
depressive symptoms.
In this respect, patients suffering from work-related stress
and resulting depression may particularly benefit from a
mindfulness-based programme (MBP). Mindfulness refers to
an originally Buddhist principle and can be defined as focus-
ing one’s attention on the present moment and simultaneously
adopting an attitude of acceptance and non-judgement (Kabat-
Zinn 1994). The present moment awareness can include body
sensations, emotional reactions, cognitions and perceptual ex-
periences. Adopting an attitude of openness towards and ac-
ceptance of one’s experience is critical, because it enables a
person to experience the present moment with a curious, de-
tached and non-reactive orientation (Creswell 2017). This
non-judgmental attention can foster a dispassionate state of
self-observation (Bishop et al. 2004). In this non-striving atti-
tude an ‘inner space’ between the individual’s perception of
events and their automatic, habitual patterns of reactivity (‘au-
topilots’) can be attained, which is thought to enable a more
reflective as opposed to reflexive ‘inner response’ to events
(Bishop et al. 2004). Indeed, experimental research has sup-
ported the idea that mindfulness disrupts otherwise automati-
cally operating processes and impulses (Papies et al. 2012),
improves attentional functions (Moore and Malinowski 2009)
and facilitates de-automisation which further cultivates adap-
tive self-regulation (Kang et al. 2013).
The use of MBPs in the treatment of a variety of psycholog-
ical problems is well established (Creswell 2017; Khoury et al.
2013). While mindfulness-based stress reduction (MBSR;
Kabat-Zinn 1982) has been shown to be beneficial for a range
of psychological and physical conditions (Bohlmeijer et al.
2010; Creswell 2017), mindfulness-based cognitive therapy
(MBCT; Segal et al. 2002, 2013) is recognised as a relapse
prevention programme for depression (Creswell 2017;
MacKenzie et al. 2018). A meta-analysis of randomised trials
of manualised MBCT for relapse prevention in recurrent de-
pression comparingMBCTwith non-MBCT treatment (includ-
ing usual care) showed that patients receiving MBCT had a
reduced risk of depressive relapse within a 60-week follow-
up period, compared with those who did not receive MBCT.
Furthermore, comparisons with active treatments suggest a re-
duced risk of depressive relapse within a 60-week follow-up
period (Kuyken et al. 2016). Extending this line of research,
preliminary results suggest that mindfulness-based
programmes are also effective for patients suffering from cur-
rent depression (Creswell 2017; Hofmann et al. 2010; Kenny
and Williams 2007; Strauss et al. 2014; Van Aalderen et al.
2012) and are helpful in the context of work-related stressors
and coping styles (Good et al. 2016; Virgili 2015).
The development of a mindful attentional focus on the
present moment and a non-judgmental, accepting and de-
tached view of one’s thoughts may be especially helpful for
patients suffering from work-related depression. First, this is
assumed because research has shown that ruminative patterns
which exacerbate and prolong distress and depression by in-
terfering with effective problem solving and instrumental be-
haviour (Nolen-Hoeksema et al. 2008) are not only typical in
depression in general but also in work-related depression spe-
cifically (Cropley and Millward Purvis 2003; Querstret and
Cropley 2012). Together with reductions in cognitive and
emotional reactivity, changes in rumination have been shown
to be mechanisms underlying the efficacy of MBPs (Gu et al.
2015). As such, mindfulness can help patients to notice and
regulate maladaptive thoughts (e.g., ‘I cannot stop until the
work is done.’), emotional responses (e.g., fear of failure),and
automatic behaviours (e.g., working until exhaustion sets in),
each of which appear to be particularly relevant in the context
of work-related depression. Learning how to monitor experi-
ence with acceptance, in particular, can foster stress resilience
and coping under stress (Creswell 2017). Second, mindfulness
practice, with its focus on increasing body awareness, might
help people get in contact with their organismic states and
needs (Hölzel et al. 2011) and restore their sense of presence
and agency in the world (Farb et al. 2015). Being aware of
organismic states and needs (e.g., hunger and thirst, tiredness,
excitement) and self-knowledge are basic requirements for
successful self-regulation (Carlson 2013; Vago and David
2012). For example, being unaware of tiredness and exhaus-
tion and a need for rest will probably prevent taking action
steps (e.g. pausing, reducing workload) to restore organismic
states. Third, being mindful of thoughts and emotions in an
open and non-judgmental waymay facilitate a greater sense of
clarity with regard to one’s values, which may in turn result in
self-congruent behaviours (Carlson 2013; Keng et al. 2011;
Levesque and Brown 2007). For example, research has shown
that higher levels of self-reported mindfulness are associated
with greater engagement in valued behaviours and interests
(Brown and Ryan 2003), less ambivalence (Haddock et al.
2017) and greater ability to engage in goal-directed behaviour
when emotionally upset (Baer and Krietemeyer 2006). This
might enable individuals in the work context to better orient
themselves towards important and valued goals.
There are a variety of evaluated occupational stress preven-
tion and intervention programmes available for non-clinical
target groups (e.g., Aikens et al. 2014; Ivancevich et al. 1990;
Joyce et al. 2016; Van der Klink et al. 2001). However, psycho-
therapeutic interventions with a focus on work-related attitudes
and behaviour patterns for patients currently suffering from
depression are still rare in routine clinical care (e.g., Beutel
et al. 2006; Koch et al. 2006; Meyer et al. 2016). This is
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surprising, as the most prominent advantage of a specialised
treatment concept is the possibility to tailor the treatment to
the needs of the specific group of patients. Specifically because
work-related experiences, conflicts and demands are addressed,
patients may choose to participate in the treatment, which could
lead to high commitment, low dropout rates and higher overall
outcome (Zeeck et al. 2013). Moreover, to the best of our
knowledge, there is no research on high-intensity interventions
(i.e., inpatient or day hospital) integrating mindfulness as a core
treatment principle. Yet, a mindfulness-based programme in a
day hospital setting, in particular, could offer several advan-
tages compared with an inpatient or outpatient setting. A day
hospital is conceptually similar to a complex inpatient treatment
setting with the difference that patients return home in the eve-
nings and for the weekends, leading to lower costs than full-
time hospitalisation (Zeeck et al. 2013). This setting offers the
additional benefit of allowing for the regular transfer and testing
of skills in patients’ daily lives during evenings and weekends.
While spending a significant amount of time in the therapeutic
milieu, patients continue to have meaningful contact with fam-
ily and their social environment and are able to practice their
new abilities, strategies or behaviour and reflect new insights
with their partners and friends. In comparison with regular
MBPs, a day hospital offers several hours of daily treatment
in a group setting over the course of 8weeks and allows patients
to develop new experiences away from the stress of work.More
importantly, it offers a much more intense period of treatment
and mindfulness practice than could be offered in outpatient
treatment settings. Consequently, larger doses may produce
larger effects (Creswell 2017). Finally, a day hospital setting
might be especially suited to assisting patients to apply mind-
fulness to everyday stressors and to develop effective coping
because, in addition to high doses of formal mindfulness train-
ing, it can offer treatment components specifically targeted to
transferring mindfulness into everyday life.
Based on the foregoing reasoning, the aim of the present
randomised controlled pilot study was to test the effectiveness
of a mindful depression treatment in a day hospital (MDT-
DH) under naturalistic conditions. The day hospital interven-
tion was specifically developed for the treatment of patients
suffering from a current episode of depression and work-
related conflicts and was integrated in the regular primary care
system. As a psychiatric department, patients also received
medical treatment based on the German guidelines for the
treatment of depression (National Guideline for Depression
DGPPN 2015) if necessary and desired. We expected that
the intensive, mindfulness-based treatment concept in a day
hospital would produce large effects, compared with a waitlist
condition which included a psychopharmacological consulta-
tion (based on the German guidelines for the treatment of
depression to ensure consistency across conditions in the type
of medication used), in reducing depression severity, promot-
ing mindfulness and improving work ability.
Method
Participants
Participants were recruited through the regular admission pro-
cess for the day hospital in the psychiatric department of the
Asklepios Klinikum Hamburg. Eligible participants were pa-
tients with a current diagnosis of moderate or severe depres-
sion and self-reported work-related stressors as the main rea-
son for their current depressive episode. Exclusion criteria
were as follows: bipolar disorder, a history of schizophrenia
or schizoaffective disorder, an organic mental disorder, a co-
morbid borderline personality disorder, eating disorder, or
substance abuse. The sample was 55.6% male, with a mean
age of 45.48 years (SD = 8.54; range 27–61) (see Table 1 for
descriptive statistics).
Procedure
This study was designed as a single-centre randomised con-
trolled trial comparing an eight-week mindful depression
treatment in a day hospital setting (MDT-DH) to a psycho-
pharmacological consultation waitlist condition (PCC). We
chose the PCC to control for time effects and effects attribut-
able to psychopharmacological treatment. Participants were
assessed over the course of 8 weeks, either during their treat-
ment in the day hospital or during the waiting period. In order
to investigate the stability of the treatment effects, participants
in the MDT-DH condition were additionally assessed
8 months after end of treatment. All study procedures were
approved by the Ethics Committee of the University of
Hildesheim. We additionally obtained research governance
approval from the local primary care health board, the
HamburgMedical Chamber. The trial was retrospectively reg-
istered with the Deutsches Register Klinischer Studien
(German Registry of Clinical Studies), No. DRKS00006314,
and conducted and reported in accordance with CONSORT
guidelines (Moher et al. 2012).
Study participants were recruited from February 2014 until
June 2015 through the regular admission process of the day
hospital (see Online Resource 1 for a description of the
admission process). Patients were either self-referred after
finding information on the treatment on the internet, were
referred to the day hospital by their general practitioners, psy-
chiatrists or psychologist or were referred by health counsel-
lors at work, with reference to the specialised treatment con-
cept. The online or flyer-based treatment description explicitly
referred to the treatment of current depression which is main-
tained by work-related stressors and conflicts. By clearly stat-
ing its therapeutic specialisation, the day hospital attracted
patients seeking therapeutic help with this specific focus.
Due to high demand and limited treatment capacity of ten
patients per month in the day hospital, the regular waiting
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period for admission to treatment was 10 weeks (between
being able to register for treatment and entering into treat-
ment). To manage the high demand, a monthly information
session for individuals interested in the treatment was
established. During this information session, the focus of the
treatment was again stated, and prospective participants were
screened for a fit with the treatment concept (i.e., current de-
pression and work-related stressors). During the study period,
we added a study information module to the monthly session
where we presented the current trial. Within this study infor-
mation module, all persons interested in the study were fully
informed of the process, duration and time investment
required.
After expressing interest in the study, each participant
signed a written consent, was given a randomly designed
pseudonym and was listed for the next study cohort.
Pseudonyms were emailed to a statistician at the University
of Hildesheim who was not otherwise involved in the study,
who randomly assigned participants to either the MDT-DH or
the PCC condition of each cohort. To ensure that the diagnos-
tic information was up to date at the first assessment, diagnos-
tic eligibility of participants in each condition was determined
with the Structured Clinical Interview for DSM-IV for depres-
sion (SCID; First et al. 1997; German version: Wittchen et al.
1997) immediately before the participants were due to start
their first online assessment. While participants were aware of
their group assignment, assessors conducting the SCID inter-
views were not aware of the participants’ assignment. The
diagnostic SCID interviews were carried out by raters who
were not part of the treatment team. All raters were psychol-
ogy students (master’s programme) or graduates and received
intense training in SCID interviews prior to the study by an
experienced SCID rater and clinician. If in doubt, each rater
was able to receive supervision from the head clinician
(psychiatrist) of the day hospital. All participants, after meet-
ing inclusion criteria, were asked to take part in the first online
self-report assessment. It should be noted that because of the
limited capacity of ten patients in each treatment cohort,
Table 1 Sample characteristics of the patients in PCC and MDT-DH at baseline and follow-up assessment
Baseline assessment Follow-up assessment
Characteristic PCC (n = 34) MDT-DH (n = 47) p value MDT-DH (n = 33) Non-completersd (n = 12) p value
Age, M (SD) 44.09 (8.95) 46.49 (8.19) 0.55a 46.55 (7.39) 47.33 (10.40) 0.78a
Male sex, n (%) 19 (55.9) 26 (55.3) 0.96b 19 (57.6) 7 (58.3) 0.96b
Highest education level, n (%) 0.06b 0.30b
Secondary education 18 (52.9) 23 (48.9) 14 (42.4) 7 (58.3)
University-entrance diploma 16 (48.1) 24 (51.1) 19 (66.7) 5 (41.7)
Marital Status, n (%) 0.58b 0.34b
Single 3 (8.8) 9 (19.1) 4 (12.1) 3 (25.0)
Steady relationship 9 (26.5) 9 (19.1) 7 (21.2) 1 (8.3)
Married 22 (52.9) 24 (51.1) 18 (54.5) 6 (50.0)
Divorced, widowed 4 (11.8) 5 (10.6) 3 (9.1) 1 (8.3)
Work status, n (%) 0.89b 0.36b
Employed 32 (94.1) 43 (91.5) 31 (93.9) 10 (83.3)
Self-employed 1 (2.9) 1 (2.1) 1 (3.0) 0 (0.0)
Seeking work 1 (2.9) 3 (6.4) 1 (3.0) 2 (16.7)
Subtypes of depression, n (%) 0.81b 0.28b
First episode 19 (55.9) 25 (53.2) 16 (48.5) 8 (66.7)
Recurrent depression c 15 (44.1) 22 (46.8) 17 (51.5) 4 (33.3)
Any Axis II morbidity, n (%) 16 (47.1) 18 (38.3) 0.43b 12 (36.4) 4 (33.3) 0.85b
Consulting psychiatrist, n (%) 14 (41.2) 23 (48.9) 0.48b 16 (48.5) 7 (58.3) 0.56b
Psychotherapy experience, n (%) 11 (32.4) 22 (46.8) 0.19b 17 (51.5) 5 (41.7) 0.56b
Mindfulness experience, n (%) 2 (5.9) 8 (17.0) 0.13b 5 (15.2) 3 (25.0) 0.45b
PCC, Psychopharmacological Consultation Control group; MDT-DH, Mindful Depression Treatment in a Day Hospital; non-completers, patients in
MDT-DH who did not complete follow-up assessment
a By independent t test
b By χ2 test
c Previous episodes stated by patients in diagnostic SCID interview
dMDT-DH patients who completed post-assessment yet did not take part in follow-up assessment
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limited staff resources and other practical constraints in the
naturalistic treatment setting (e.g., one patient’s cancellation
of treatment participation at short notice and the subsequent
elevation of another patient from the waiting list), we aimed to
maximise trial participation in each cohort and adjusted the
randomisation ratio for each cohort throughout the trial.
Data collection took place over the course of 22 months,
from April 2014 until February 2016 (see Online Resource 1
for the data collection process). All outcomes were assessed at
baseline and post-treatment. Depression severity was also
assessed in the middle of the treatment. The primary outcome
was depression severity at post-treatment. InMDT-DH further
data was collected at follow-up 8 months after post-treatment.
Please note that further online self-report assessments and
separate computer-based assessments were administered in a
subsample of this study. The results were not relevant to the
current study aims and are reported elsewhere (Remmers et al.
2017; Remmers et al. 2018). Two additional secondary out-
comes (self-compassion and work-related behavioural and ex-
periential patterns) were measured, which will also be present-
ed elsewhere.
The current study includes data from 13 cohorts with 81
participants who were willing to participate and met the inclu-
sion criteria. In theMDT-DH group, 48 patients participated in
the study during the clinical treatment and three patients
(6.3%) dropped out of the study (but continued the MDT-
DH treatment), one of them without any baseline assessment
(see Fig. 1 CONSORT diagram). None of the participants in
either MDT-DH or PCC dropped out of the day hospital treat-
ment. In the PCC group, 34 participants took part, of which
two (5.9%) dropped out of the study but still wanted to be
admitted to treatment after the waiting period. All dropouts
during the study, irrespective of the group condition, stated
that they felt overburdened with the time and concentration
effort necessary to conduct the online assessments. In the
MDT-DH group, 45 (93.7%) patients completed the assess-
ments from baseline to post-assessment and in the PCC group,
32 participants (94.1%) provided complete assessments. Eight
months after end of treatment, 33 patients (73.3%) within the
MDT-DH group completed the follow-up assessment.
Patients who did not complete the follow-up in the MDT-
DH did not respond to enquiries. Consequently, we were un-
able to assess the reasons for non-completion.
Mindful Depression Treatment in a Day Hospital The psychi-
atric day hospital was established in 2009 as part of the pri-
mary care and health system in Hamburg. MDT-DH followed
a structured and intense eight-week treatment concept in
which the cultivation of a mindful mind-set (i.e. practicing
focusing one’s attention on the here-and-now and adopting
an accepting, non-judgmental attitude) was the basis of the
therapeutic rationale. The focus, throughout the treatment,
was on coping with work-related conflicts, resulting stress
and interpersonal situations in which patients learned to apply
a mindful mind-set (e.g., adopting a non-judgmental attitude
when facing conflicting interpersonal interests as opposed to
automatically reacting with anger). At the heart of MDT-DH
was the daily practice of formal (sitting meditation, 25 min)
and informal mindfulness (e.g., mindful bodywork such as
yoga or qigong, for a minimum of 50 min daily). There were
also two weekly sessions of mindfulness-centred group ther-
apy (e.g., awareness of emotions and their influence on the
body or keeping a mindful mind-set in difficult situations,
100 min) and two weekly sessions of interactional group ther-
apy (e.g., biographical experiences and personal belief sys-
tem, or conflict management, 100 min). The interactional
group therapy included cognitive behavioural therapy ele-
ments (e.g., identifying stress-intensifying thoughts) similar
to those promoted in MBCT (Segal et al. 2013). These core
elements were complemented by depression-related and
work-related psychoeducation (50 min, twice a week) and
physical activity (e.g., NordicWalking, 50min, twice a week),
as well as four individual psychotherapy sessions over the
course of the treatment (each 50 min). Each treatment day
consisted of four or five treatment modules that were carried
out as a group-based intervention: the morning meditation for
25 min, one module of 100 min and two or three of 50 min,
amounting to a minimum of 225 min per day (see Online
Resource 2 for a depiction of the weekly schedule). Over the
course of 8 weeks, patients received 150 h of treatment in
total.
The treatment concept and the respective modules were
based on three defined pillars (with each treatment module
adding new ways of relating to automatic work-related behav-
iour and thoughts, promoting disengagement, letting go (e.g.,
of perfectionism), acceptance and present-moment aware-
ness). The first pillar of the treatment concept aimed at
instructing practice in formal (i.e., meditation) and informal
mindfulness exercises (e.g., being mindful while preparing
and eating meals). The body and activation-based treatment
modules (i.e., Yoga, Qigong, Nordic Walking), for example,
were conceptualised to promote awareness for bodily states
and needs. Patients were instructed to develop an awareness of
their physiological stress limit and to recognise the early onset
of stress and exhaustion. Other practical treatment modules,
such as plasticising or cooking, were conceptualised to pro-
mote a mindful mind-set in everyday actions, i.e. while doing
manual work or domestic chores. The patients were instructed
to execute daily routines like cooking, Nordic walking or
working with their hands with a mindful awareness and to
savour the difference in the sensual input. The second pillar
of the treatment concept aimed to help patients become ex-
perts of their own psyche by imparting knowledge on, e.g., the
onset of specific symptoms, research findings on stress and
depression and meditation outcomes, or reflection and under-
standing of biographical experiences and the resulting mind-
Mindfulness (2020) 11:384–400388
set. It was essential to the treatment concept to identify auto-
matic emotional or cognitive reactions to stressors (‘autopi-
lots’) (Hülsheger et al. 2013; Siegel 2009) and to develop an
understanding of how they shape (re)actions. While some
psychoeducation modules focused on topics relevant to under-



































134 patients were asked to participate in a preliminary monthly information group session
116 patients were willing to participate and were randomized (in 13 cohorts)
65 were allocated to MDT-DH 51 were allocated to PCC
1 patient did not complete any assessment
1 patient only completed baseline 
assessment
1 patient discontinued participation before 
mid-treatment assessment
1 patient only completed baseline 
assessment
1 patient discontinued participation before 
post assessment
12 patients did not reply to our request for 
participation in follow-up assessment
8 patients withdrew after being allocated to 
PCC and before SCID 
11 patients were excluded after the SCID, 
not meeting inclusion criteria
45 patients participated in post assessment 32 patients participated in post assessment
33 patients participated in follow-up 
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34 patients in MLA analysis 











1 patient withdrew after being allocated to 
MDT-DH and before SCID
16 patients were excluded after the SCID, 
not meeting inclusion criteria
48 were allocated to MDT-DH 34 were allocated to PCC
Fig. 1 CONSORT flow diagram. MDT-DH, Mindful Depression Treatment in a Day Hospital; PCC, Psychopharmacological Consultation Control
group
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communication skills and conflict de-escalation (e.g., learning
to accept criticism, setting boundaries in a calm and deter-
mined manner and giving constructive feedback). The third
pillar aimed at further promoting the patients’ progress from
theoretical reflection on mindfulness to practical application
of a mindful mind-set in their everyday life by asking patients
to perform specific homework, e.g. daily meditation, or by
planning a detailed return to work strategy. Please see
Online Resource 3 for a brief overview of the treatment con-
cept and contents over the course of the 8 weeks.
The intervention providers consisted of two trained clini-
cians (clinical psychologist and psychiatrist) with extensive
mindfulness experience (e.g., daily mindfulness practice, par-
ticipation in retreats), and two certified MBSR/MBCT-
teachers. The occupational therapists and nursing staff all
attended an MBSR course in preparation of their work. All
day hospital employees regularly practiced mindfulness, fre-
quently participated in the morning meditation practice at the
day hospital, and were willing and able to embody a mindful
mind-set as patient role models. In addition, all day hospital
patients were offered medication based on the German guide-
lines for the treatment of depression (National Guideline for
Depression DGPPN 2015). Patients took part in weekly med-
ical rounds with the senior physician, in which psychophar-
macological treatment was prescribed if necessary.
Psychopharmacological Consultation Condition The effects of
theMDT-DHwere compared with a control condition in which
participants waited to receive the treatment in the day hospital.
We wanted to ensure that the two groups did not show system-
atic differences in medication use. For this reason, participants
in the PCC group received a psychopharmacological consulta-
tion with the same day hospital physician who consulted pa-
tients in the MDT-DH group and were given an individualised
written medical recommendation for their general practitioner
or psychiatrist. This consultation took place at the start of their
participation in the study to equate any medical treatment dur-
ing the waiting time with the usual psychopharmacological
treatment in the day hospital. All participants in the PCC group
received the MDT-DH treatment after the waiting period.
Measures
Work-Related Stressors As the day hospital has a clear focus
on work-related stressors, a history of stressors leading to the
current crisis was determined in a short telephone interview
before inviting patients to attend the information session (see
Recruitment). After being included in the study, work-related
stressors were assessed in the demographic questionnaire in
the baseline assessment (“In your opinion, which of the fol-
lowing occupational stress factors contributed to your current
crisis and exhaustion? Please select none, one or more of the
options listed, or add another option: e.g., conflicts with supe-
riors, conflicts with colleagues, high workload and overtime,
increased performance expectations, fear of job loss”).
Primary Outcome We used the Beck Depression Inventory
(BDI-II; Beck et al. 1996; German version; Hautzinger et al.
2006) to assess depression severity as primary outcome. The
BDI-II is a well-known 21-item self-assessment questionnaire
that covers cognitive, affective, motivational and somatic
symptoms of depression. The test-retest reliability of the BDI-
II is adequate (ranging from 0.73 to 0.96), as is its internal
consistency (0.9) and validity in clinical samples (Wang and
Gorenstein 2013). The internal consistency (Cronbach’s alpha)
over the course of this study was between 0.83 and 0.95.
Secondary Outcomes To assess mindfulness, we used the
Kentucky Inventory of Mindfulness Skills (KIMS-D; Baer
et al. 2004; German version: Ströhle et al. 2010), a 39-item
self-report inventory covering four behaviourally oriented
facets of mindfulness: observing or attending to internal and
external stimuli (e.g., ‘I notice when my moods begin to
change’), describing and labelling phenomena non-
judgmentally (e.g., ‘I’m good at finding words to describe
my feelings’), acting with awareness in which undivided at-
tention is focused on one thing at a time (e.g., ‘When I do
things, I get totally wrapped up in them and don’t think about
anything else’), and accepting or allowing present moments or
events to occur without judging them (e.g., ‘I tell myself that I
shouldn’t be feeling the way I’m feeling’). The German KIMS
scales show adequate to good internal consistency (α > 0.76).
The test-retest reliabilities of the four scales were between
0.65 and 0.86 (Baer et al. 2004; Baum et al. 2010). Internal
consistencies (Cronbach’s alpha) among each of the KIMS
subscales over the course of this study were as follows: ob-
serve = 0.92–0.95, describe = 0.89–0.95, act with awareness =
0.78–0.89, act without judgement = 0.90–0.95.
To assess work ability we used the Work Ability Index
(WAI; Tuomi et al. 1994). TheWAI is a self-administered ques-
tionnaire with seven items (e.g., “How do you rate your current
work ability with respect to the physical/mental demands of
your work?”; “Do you believe, according to your present state
of health, that you will be able to do your current job two years
from now?”). It assesses a worker’s ability to perform his or her
job, taking into account specific psychosocial and physical
work-related factors, mental and physical abilities, and health
(van den Berg et al. 2008), and comprises the following aspects:
(i) subjective estimation of present work ability compared with
the lifetime best, (ii) subjective work ability in relation both to
physical and to mental demands of the work, (iii) number of
diagnosed diseases, (iv) subjective estimation of work impair-
ment due to disease, (v) number of days away from the job due
to sickness during the past year, (vi) one’s own prognosis of
work ability in 2 years, and (vii) mental resources (to enjoy
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daily activities, etc.). Based on the WAI score, an individual’s
work ability can be classified into four categories: poor (7–27),
moderate (28–36), good (37–43) and excellent (44–49). In an
extensive international survey of 38,000 nurses from ten
European countries, the internal reliability (Cronbach’s alpha)
for the total sample was found to be satisfactory at 0.72
(Radkiewicz et al. 2005). A factor analysis did not support the
implicit assumption of the homogeneity of the WAI, but rather
showed that the seven items group into two factors: (1) subjec-
tive assessment of ability to work and one’s own mental re-
sources and (2) objective information concerning one’s own
health and absenteeism due to illness. However, for the
German sample a single-factorial solution was determined
(Radkiewicz et al. 2005). Analyses of correlations showed the
predictive power of WAI to be strong and consistent, and in the
expected direction. The higher the WAI score, the higher an
individual’s General Health Index (r = 0.67) (Radkiewicz
et al. 2005). The WAI and all its items reliably predicted work
disability, retirement and mortality (Ilmarinen 2007). The inter-
nal consistency (Cronbach’s alpha) over the course of this study
was between 0.54 and 0.77.
Data Analyses
Prior to our main analyses, we conducted independent t tests
(continuous variables) and χ2 tests (categorical variables) on
all available baseline information to rule out systematic differ-
ences between treatment and control conditions (MDT-DH vs.
PCC). Furthermore, we explored potential differences in base-
line characteristics between dropouts and completers using χ2
test or t test.
For our main analyses, we used linear mixed-effects
models to examine effects of group assignment (treatment or
control group) and treatment duration on outcome. A linear
effect of time was included as well as the treatment condition
and an interaction term of time and treatment condition. The
individuals nested in cohorts represent a grouping factor and
were introduced as a random effect in the model. In order to
control for medication effects (psychopharmacological medi-
cation vs. no medication) and number of depressive episodes
(first episode vs. recurrent), we included these variables as
factors in the model. Due to a lack of support for an overarch-
ing mindfulness factor (Baum et al. 2010), we used the sum of
each KIMS subscale in a second analysis to explore whether
facets of mindfulness were differentially affected. We includ-
ed the four mindfulness subscales as additional variables in
the mixed model. As this exceeded the possible number of
estimated parameters, we excluded the medication effects
and number of depressive episodes as factors for this analysis
and only modelled for the correlation of repeated measure-
ments per participant. Significance of fixed effects was deter-
mined by Satterthwaite’s method for approximating the
degrees of freedom (Satterthwaite 1946). All analyses were
performed using R (Team 2018) and the package lme4
(Bates et al. 2015) and lmerTest (Kuznetsova et al. 2017).
In order to estimate the pre-post effect sizes for patients
within MDT-DH on outcome variables without consideration
of model parameters, we calculated Cohen’s d (Cohen 1988)
based on observed values as dRepeated Measures (dRM). This was
done by correcting the standard deviation based on the corre-
lation between baseline and post-assessment (Morris and
DeShon 2002) and using the standard deviation of the baseline
(Morris 2008): σD ¼ σ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2 1−ρð Þp . Furthermore, to esti-
mate the effect sizes for the difference betweenMDT-DH (n =
45) and PCC (n = 32) at post-assessment, we calculated
Hedges’ g (Hedges and Olkin 1985) on the basis of Cohen’s
d (Cohen 1988) by adjusting the calculation of the pooled
standard deviation with weights for the reduced sample size
in PCC. All calculations were computed with tools offered by
Psychometrica (Lenhard and Lenhard 2016).
Especially in a clinical context, it is important to not only
determine the statistical significance of self-reported changes
in depression severity but also the clinical relevance of the
results. Thus, we used the Jacobson and Truax (1991) formula
for ‘reliable change’ (RC) in depression severity based on the
reliability of the BDI-II (rtt = .78) (Kühner et al. 2007) to al-
locate patients to one of four clinical change categories. A
BDI-II score difference was considered ‘improved’ if the RC
was less than or equal to − 1.96 (95% confidence interval). A
BDI-II score difference was considered clinically meaningful
and ‘reliably improved’ if, in addition to being improved, the
BDI-II value passed the cut-off score of 14 (minimal depres-
sion) in a non-clinical population. A BDI-II score difference
was considered ‘unchanged’ if the RC was between − 1.96
and 1.96 and ‘deteriorated’ if the RC was more than 1.96.
We calculated a χ2 test to test for difference in the clinical
change category between participants in MDT-DH and PCC.
With respect to the participants work ability, we were in-
terested to determine the changes in the respective Work
Ability Index (WAI) categories. We therefore additionally
computed mean scores in work ability at baseline and post-
assessment, as well as at follow-up 8 months after post-
assessment for participants with complete data (n = 81). A
chi-square test was calculated comparing the distribution of
index categories in the WAI in both group conditions at base-
line and post assessment.
Results
Descriptive Statistics and Baseline Characteristics
All included study participants (N = 81) reported one or more
work-related stressors (see Table 2). We found no significant
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group differences in any of the sociodemographic or clinical
variables (all p values > 0.05) (see Table 1 for sample
characteristics at baseline assessment and Table 3 for
outcome measures). Furthermore, the percentage of partici-
pants using psychopharmacological medication in PCC and
MDT-DH did not differ significantly at the baseline assess-
ment (PCC n = 15, 44.1%; MDT-DH n = 15, 31.9%; p = 0.26)
nor at post-assessment (PCC n = 14, 43.8%; MDT-DH n = 17,
37.8%; p = 0.60). In addition, we found no significant differ-
ences in the types of pharmacological treatment received by
participants in PCC andMDT-DH over the course of the study
(see Online Resource 4).
Dropout and Non-participation
Even though a few participants (6.2%) discontinued participa-
tion in the study (MDT-DH n = 3; PCC n = 2), no participant
dropped out of the actual treatment. Thus, non-participation in
MDT-DH did not lead to discontinuation of the treatment, nor
did it change the desire to be admitted to treatment in former
PCC participants. Nevertheless, we checked for a possible
systematic bias in participants who discontinued study partic-
ipation and found a significant difference in baseline depres-
sion severity, t(45) = − 3.13, p = 0.003, between MDT-DH pa-
tients who completed post-assessment (n = 45, M = 24.62,
SD = 7.23) and those who no longer participated (n = 2, M =
41.00, SD = 7.07). In the PCC, we found no difference in
baseline depression severity between participants who com-
pleted post-assessment (n = 32, M = 26.78, SD = 7.82) and
those who no longer participated (n = 2, M = 24.5, SD =
9.19), t(32) = 0.40, p = 0.693. With regard to the patients
who no longer participated in MDT-DH after post-
assessment (n = 12) and patients with complete data (n = 33)
who took part in the follow-up assessment 8 months later, we
found no differences in sample characteristics (all p values >
0.05, see Table 2) and outcomes (see Table 3). These results
suggest that non-participation did not occur due to systematic
differences in depression severity, work ability or mindfulness
levels, but resulted from other reasons unknown to the
authors.
Effectiveness of MDT-DH vs. PCC
The mixed effects models showed a non-significant effect of
time and treatment condition (p > .05), but a significant time
by group interaction for all outcome measures (BDI-II, KIMS,
WAI). Furthermore, the results show that the outcome mea-
sures remained relatively stable in PCC during the waitlist
period, but changed favourably in MDT-DH. All estimated
parameters are summarised in Table 4. The change patterns
are visualised in Fig. 2. The improvements observed in the
MDT-DH condition remained stable over the follow-up
Table 2 Self-reported work-
related stressors (sorted by
percentage)
N = 81 PCC (n = 34) MDT-DH (n = 47) p value
n % n % n %
High workload and overtime 58 71.6 25 73.5 33 70.2 0.74
Increased expectations of performance 49 60.5 23 67.6 26 55.3 0.26
Conflicts with superiors 35 43.2 13 38.2 22 46.8 0.44
High amount of work-specific conflicts 34 42.0 15 44.1 19 40.4 0.74
No or too few breaks 32 39.5 17 50.0 15 31.9 0.10
Overtime without compensation 31 38.5 13 38.2 18 38.3 0.99
Conflicts with colleagues 28 34.6 8 23.5 20 42.6 0.08
Lack of flexibility in work processes 21 25.9 9 26.5 12 25.5 0.92
Increased responsibility 19 23.5 10 29.4 9 19.1 0.28
New job/responsibilities due to restructuring 19 23.5 8 23.5 11 23.4 0.99
Fear of job loss 17 21.0 8 23.5 9 19.1 0.63
Boring and uninteresting work 10 12.3 4 11.8 6 12.8 0.89
Shift work 9 11.1 3 8.8 6 12.8 0.58
Too few demands and underload 5 6.2 1 2.9 4 8.5 0.30
High amount of travel 3 3.7 1 2.9 2 4.3 0.76
Constant availability 3 3.7 1 2.9 2 4.3 0.76
Other/additional work-related stressors 21 25.9 10 29.4 11 23.4 0.54
Work-related stressors were assessed by questionnaire at the baseline assessment. Patients could choose none, one
or more stressors from a predefined list and state additional stressors. Additional stressors (e.g., sales force
activities, 24-h duty, work life crisis, conflict with a customer) were only listed above if more than one patient
stated them. The p value was calculated by χ2 test
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period. Inclusion of the use of psychopharmacological medi-
cation in the model, to preclude the influence of medication
use on the treatment effect, found no evidence for an effect of
psychopharmacological medication between the treatment
conditions. In a further exploratory analysis, we included the
number of depressive episodes (first vs. two or more episodes)
as a factor and found a non-significant effect of the number of
episodes on depression severity (p = 0.063) and a significant
effect on mindfulness (p = 0.006). This indicates that partici-
pants with a recurrent depression are on average more de-
pressed and significantly less mindful than participants with
a first episode. Furthermore, we found that all four subscales
changed over the course of the study in MDT-DH but
remained stable in PCC. This indicates that the MDT-DH
treatment leads to significant and stable changes in different
facets of mindfulness.
Table 3 Observed means and standard deviations (in parentheses) in outcome measures in PCC, MDT-DH and patients who did not complete follow-
up (non-completer) over the course of the study
PCC M (SD) MDT-DH M
(SD)
t (79)c p valuec MDT-DHb
(n = 33) M (SD)
Non-completerd
(n = 12) M (SD)
t (43) e p valuee
BDI-II
Baselinea 26.65 (7.77) 25.32 (7.91) 0.75 0.455
Post 26.19 (8.40) 10.04 (9.30) 10.18 (8.29) 9.67 (12.09) − 0.16 0.872
Follow-upb – 11.39 (10.47)
WAI
Baselinea 20.32 (4.74) 20.73 (6.04) 0.33 0.743
Post 19.81 (4.82) 29.00 (7.53) 29.50 (7.34) 27.63 (8.21) − 0.74 0.467
Follow-up b – 31.45 (8.38)
KIMS (total)
Baselinea 2.78 (0.38) 2.88 (0.42) − 1.10 0.276
Post 2.76 (0.38) 3.53 (0.53) 3.51 (0.44) 3.54 (0.57) − 0.16 0.877
Follow-upb – 3.40 (0.56)
KIMS-O
Baselinea 32.85 (8.01) 34.51 (8.14) − 0.911 0.365
Post 33.94 (7.58) 42.56 (7.43) 43.24 (7.91) 40.67 (5.80) − 1.03 0.309
Follow-upb – 39.49 (8.65)
KIMS-D
Baselinea 21.77 (6.42) 22.17 (6.79) − 0.271 0.787
Post 22.22 (6.20) 28.49 (5.72) 28.79 (6.14) 27.67 (4.49) − 0.58 0.567
Follow-upb – 26.21 (7.49)
KIMS-A
Baselinea 26.48 (5.54) 26.77 (6.37) − 0.217 0.829
Post 25.72 (5.23) 32.82 (7.28) 32.88 (7.17) 32.67 (7.89) −.09 .932
Follow-upb – 31.82 (5.59)
KIMS-J
Baseline a 27.38 (7.95) 28.89 (8.01) −8.41 0.403
Post 25.75 (5.83) 33.78 (7.17) 33.03 (7.12) 35.83 (7.21) 1.16 0.251
Follow-up b – 34.97 (8.63)
PCC, Psychopharmacological Consultation Control group; MDT-DH,Mindful Depression Treatment in a Day Hospital. BDI-II,Beck Depression
Inventory-II; WAI,Work Ability Index; KIMS (total), Kentucky Inventory of Mindfulness Skills; KIMS-O, subscale observe; KIMS-D, subscale de-
scribe; KIMS-A, subscale act with awareness; KIMS-J, subscale act without judgement. The baseline assessment took place at the start of the study and
post-assessment was 8 weeks after baseline. The follow-up assessment was conducted 8 months after post assessment. There was no follow-up in PCC
a Please note that at baseline we analysed all patients with available data (N = 81), yet at post-assessment there where 2 patients per treatment condition
who discontinued the study
b Only 33 patients in the MDT-DH participated in the follow-up
c All t and p values stated refer to a comparison of outcomes between PCC and MDT-DH at baseline
d MDT-DH patients with post-assessment data, but without follow-up data (n = 12)
e All t and p values stated refer to a comparison in post-assessment outcomes between patients who completed follow-up inMDT-DH and those, who no
longer participated after post-assessment
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Based on observed means within the MDT-DH condition,
we found large effect sizes for the reduction in depression
severity, dRM = 1.93, 95% CI [1.44, 2.42], and the increases
in work ability, dRM = 1.19, 95% CI [0.75, 1.63], and
mindfulness, dRM = 1.22, 95% CI [0.78, 1.67], at post-assess-
ment. Effect sizes for the increases in the four subscales at
post-assessment were as follows: observe, dRM = .83, 95%
CI [0.41, 1.25], describe, dRM = 1.02, 95% CI [0.59, 1.45],
act with awareness, dRM = 0.79, 95% CI [0.37, 1.20] and act
without judgement, dRM = 0.67, 95% CI [0.25, 1.08].
Furthermore, comparing MDT-DH with PCC at post-assess-
ment, we found large effect sizes for depression severity,
gHedges = 1.80, 95% CI [1.27, 2.34], work ability, gHedges =
1.40, 95% CI [0.89, 1.91] and mindfulness, gHedges = 1.62,
95% CI [1.10, 2.14]. Effect sizes for the increases in the four
subscales were as follows: observe, dRM = 1.15, 95%CI [0.66,
1.64], describe, dRM = 1.06, 95% CI [0.58, 1.54], act with
awareness, dRM = 1.09, 95% CI [0.61, 1.58] and act without
judgement, dRM = 1.21, 95% CI [0.72, 1.70].
Clinical Change and Work Ability Categories
The distribution of clinical change categories, WAI scores and
categories is presented in Table 5. At post-assessment, 33
(73.3%) MDT-DH patients with complete data (n = 45)
showed an improvement in depression severity, of which 29
(64.4%) were reliably improved. In the PCC (n = 32), four
patients showed an improvement, of which two could be la-
belled reliably improved (6.3%). There was a highly signifi-
cant difference in the distribution of clinical change categories
between PCC and MDT-DH at post-assessment, χ2 (2) =
28.11, p < 0.001. Furthermore, results did not reveal a signif-
icant association between the distribution of WAI categories
and the treatment condition at baseline assessment, χ2 (1) =
0.79, p = 0.372, yet a highly significant association at post-
assessment, χ2 (2) = 20.42, p < 0.001.
Discussion
The current randomised controlled pilot study investigated the
effectiveness of a mindfulness-based treatment for depression
and work-related conflicts under the naturalistic conditions of
a day hospital setting integrated in the regular health care
system. The preliminary findings support our hypothesis that
MDT-DH outperforms the PCC on self-report measures of
depressive symptoms, work ability and mindfulness and sup-
port the effectiveness of MDT-DH on depression severity,
mindfulness and work ability. Effects were assessed at the
end of treatment and appeared to remain stable over an 8-
month follow-up period. Additional analyses of the differen-
tial effects of the four mindfulness subscales showed that
changes were observable in each mindfulness facet.
Altogether, the current results indicate that a mindfulness-
based approach can be successfully established in a day hos-
pital setting. This might offer more seriously depressed pa-
tients, who are in need of more intensive treatment than the
Table 4 Parameter estimates and standard errors of the linear mixed
models
Outcome b SE df t p
BDI-II Intercept 24.94 1.82 38.55 13.720 < 0.001
Medication 0.68 1.49 132.75 0.452 0.652
Recurrent episodes 3.11 1.65 74.33 1.884 0.063
Time − 0.09 0.18 32.49 − 0.486 0.630
MDT-DH − 1.45 1.67 71.36 − 0.868 0.388
MDT-DH × time − 1.78 0.22 72.83 − 8.044 < 0.001
WAI Intercept 20.93 1.16 135.77 18.004 < .001
Medication − 0.10 1.02 131.14 − 0.981 0.328
Recurrent episodes − 0.37 0.10 144.94 − 0.369 0.712
Time − 0.05 0.19 46.09 − 0.250 0.803
MDT-DH 0.37 1.35 117.33 0.276 0.783
MDT-DH × time 1.11 0.24 105.84 4.542 < 0.001
KIMS Intercept 2.84 0.08 142.50 34.735 < 0.001
Medication 0.07 0.07 151.88 0.930 0.354
Recurrent episodes − 0.20 0.07 150.74 − 2.764 0.006
Time − 0.00 0.01 67.34 − 0.246 0.806
MDT-DH 0.11 0.10 139.49 1.173 0.243
MDT-DH × time 0.09 0.02 147.13 5.077 < 0.001
KIMS-O Intercept 32.85 1.34 124.99 24.497 < 0.001
Time 0.10 0.80 75.78 0.596 0.553
MDT-DH 1.66 1.76 124.99 0.942 0.348
MDT-DH × time 0.90 0.23 75.57 3.926 < 0.001
KIMS-D Intercept 21.77 1.08 110.02 20.214 < 0.001
Time 0.04 0.12 77.18 0.326 0.745
MDT-DH 0.41 1.41 110.02 0.287 0.775
MDT-DH × time 0.76 0.15 77.03 5.049 < 0.001
KIMS-A Intercept 26.47 1.08 139.80 24.633 < 0.001
Time − 0.09 0.16 78.72 − 0.599 0.551
MDT-DH 0.29 1.41 139.80 0.209 0.834
MDT-DH × time 0.85 0.21 78.47 4.089 < 0.001
KIMS-J Intercept 27.38 1.27 115.98 21.630 < 0.001
Time − 0.17 0.15 75.92 − 1.138 0.259
MDT-DH 1.51 1.66 115.98 0.909 0.365
MDT-DH × time 0.78 0.19 75.74 3.999 < 0.001
Mean scores at baseline for the reference group, medication effect, num-
ber of depressive episodes effect, time effect, group effect and interaction
effect between time and group.MDT-DH, Mindful Depression Treatment
in a Day Hospital (n = 47). BDI-II, Beck Depression Inventory-II; WAI,
Work Ability Index; KIMS, Kentucky Inventory of Mindfulness Skills;
KIMS-O, subscale observe; KIMS-D, subscale describe; KIMS-A,
subscale act with awareness; KIMS-J, subscale act without judgement.
The baseline assessment took place at the start of the study; post-
assessment was 8 weeks after baseline. The follow-up assessment was
conducted 8 months after post-assessment
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classical 8-week MBSR or MBCT intervention, a higher
dosed mindfulness-based treatment. In contrast to inpatient
settings, the MDT-DH provides patients with more opportu-
nities to transfer mindfulness and other skills into their daily
lives.
Strengths of this study include the use of a randomised
controlled trial design under naturalistic treatment conditions
in a day hospital. The study design, however, did not include
an active treatment in comparison with control for non-
mindfulness-specific treatment factors (e.g., home practice ex-
ercises, relaxation and placebo expectancies). It is therefore
not possible to evaluate whether MDT-DH has a unique treat-
ment effect above and beyond common therapeutic factors
(e.g., group support, more extended attention from therapists)
Fig. 2 Observed mean (±
standard error) of depression
(BDI-II), work ability (WAI) and
mindfulness (KIMS) subscales
and score values over time for
control (PCC,
Psychopharmacological
Consultation Control) and treat-
ment group (MDT-DH, Mindful
Depression Treatment in a Day
Hospital). KIMS-O, subscale ob-
serve; KIMS-D, subscale de-
scribe; KIMS-A, subscale act
with awareness; KIMS-J,
subscale act without judgement
Table 5 Clinical change categories (CCC) andWork Ability Index (WAI) scores and diagnostic categories in PCC andMDT-DH over the course of the
study
PCC MDT-DH
Time of assessment Baseline assessment Post-assessment Baseline assessment Post-assessment Follow-up assessment
n 34 32 47 45 33
CCC categoriesa
Reliably improved – 0 – 29 –
Improved – 4 – 4 –
Unchanged – 27 – 12 –
Deteriorated – 1 – 0 –
WAI M (SD) 20.32 (4.74) 19.91 (5.24) 20.73 (6.04) 28.45 (7.84) 31.45 (8.38)
WAI range 10–31 11–31 11–32 11–42 9–46
WAI categoriesb
Very good 0 0 0 0 2
Good 0 0 0 9 7
Moderate 4 5 9 21 15
Critical 30 29 38 17 9
PCC, Psychopharmacological Consultation Control group;MDT-DH, Mindful Depression Treatment in a DayHospital;CCC, clinical change categories
based on reliable change (RC); WAI, Work Ability Index. Please note that only 33 patients in the MDT-DH participated in the follow-up. Means and
standard deviations at the baseline assessment were calculated with all available data (N = 81)
a Clinical change was only assessed at post-assessment (n = 77)
b An individual’s work ability (WAI) can be classified into four categories (by mean score): critical (7–27), moderate (28–36), good (37–43) and very
good (44–49)
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or non-mindfulness-specific factors (e.g., psychoeducation,
cognitive restructuring).
We optimised the waitlist condition by integrating a
consultation with our day hospital physician at the start
of PCC to equate the medical treatment during the waiting
time with the usual psychopharmacological medication in
the day hospital. By doing this, we aimed to eliminate the
influence of the patients’ psychopharmacological treat-
ment in the analyses of the effectiveness of MDT-DH.
These findings therefore provide a valuable initial evalua-
tion of whether MDT-DH has an impact on outcomes
above and beyond standard care or no treatment.
However, we must point out that while the majority of
participants in the waitlist condition were on sick leave
during this time, some may have continued to work. The
continuing stress of work may have had an influence on
symptom severity and motivation to participate in the
study. Future studies should compare MDT-DH with active
control conditions to determine the role of mindfulness and
the comparative effectiveness of mindfulness-based
programmes in general (see MacKenzie et al. 2018) and
the current MDT-DH approach in specific. Designs using
a waitlist condition should make sure that all participants
have a comparable stress level and should control for sick
leave during participation.
Limitations and Future Research
The Cohen’s d effect sizes we found are large in magni-
tude and higher than those observed in meta-analyses on
MBPs (Hofmann et al. 2010; Khoury et al. 2013).
However, these comparisons should be drawn tentatively
because of difference in study samples, designs and ana-
lytic strategies between the studies included in these meta-
analyses and our present study (Goldberg et al. 2018).
Furthermore, the large effects we observed for the MDT-
DH may simply be due to the high dose of treatment.
Compared with MBCT, which consists of one pre-class
interview and eight group sessions of 2.5 h, the treatment
dose of 150 h in the current study was much higher. In
addition to dose effects, the high and stable treatment
gains observed may also be attributable to the specific
interplay between intensive daily formal mindfulness
training and the transfer to informal mindfulness practice
and work-related problems. Future studies should explore
these open questions. We would also like to point out that
findings on the work ability of patients should be
interpreted with caution, as the internal consistency
(Cronbach’s alpha) over the course of this study was rel-
atively low. Future studies should use structurally
matched conditions or a dismantling design to compare
different treatment doses. By this means, factors
explaining differential treatment effects may be elucidated
in a methodologically more rigorous manner. Further re-
search should also include data on the cost effectiveness
of different settings, i.e., outpatient, inpatient and day
hospital.
A further weakness of the study design is the process of
participant inclusion and randomisation to study condition.
Due to procedural aspects of the day hospital admission, we
did not ascertain inclusion criteria before allocation to condi-
tion. This led to an uneven distribution of participants to the
study conditions, which we tried to compensate for by
adjusting the allocation ratio throughout the study. Having to
allocate participants to study condition before the preliminary
diagnostic interview took place resulted in 24.6% of theMDT-
DH and 20% of the PCC participants not fulfilling the study
inclusion criteria. The resultant uneven distribution was exac-
erbated by the fact that more participants declined participa-
tion (18%) after learning that they had been allocated to the
PCC group and not the MDT-DH. The main reason stated for
post-randomisation dropout was the time and effort participa-
tion in the PCC condition posed. The highest no-show rate
was during summer school holidays (during which the PCC
treatment would have taken place) because of a lack of
childcare options. We would also like to point out that partic-
ipants in PCC may have been disappointed to have been
randomised to the control condition instead of MDT-DH,
which could have led to demoralisation and subsequent in-
crease in depression scores. Participants in MDT-DH, on the
other hand, may have felt motivated and therefore less de-
pressed. However, there were no significant baseline differ-
ences in depression scores between conditions and only a
minimal descriptive difference. Therefore, we do not see
grounds for a substantial bias. If the above-mentioned effect
on depression severity within the MDT-DH group occurred,
with subsequent minimally decreased depression scores, it
likely would have led to a statistically even more conservative
estimate of the effectiveness of the MDT-DH. It is also impor-
tant to point out that there was no procedure to monitor reli-
ability of SCID ratings among raters and no procedure for
establishing treatment fidelity. Future research should ideally
use clinically experienced raters for the SCID interviews and
monitor for reliability as well as for treatment fidelity.
The MDT-DH treatment concept is highly tailored to
depressed patients with work-related conflicts. This might
be a beneficial feature of the programme because the main-
taining factors of depression can be specifically addressed.
However, this might also limit the generalisability of the
results of our trial. The pre-selection of patients by the
treatment focus on work-related conflicts could have led
to a specific and high-performance subgroup of depressive
patients. Because of their motivation to return to their
workplace and their former performance or functioning,
patients in our study might have been more willing to en-
gage in treatment and to participate in the treatment
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components that were offered in MDT-DH. Furthermore,
the sample was well educated and might have been able to
reflect on the inner conflict more intensely, which could
have further facilitated their improvement within treat-
ment. Finally, a majority of patients were partnered and
had good social support, which may have promoted a
stronger exchange of ideas and provided more feedback
in comparison with patients who were single or had few
friends. Correspondingly, the specific subgroup of depres-
sive patients included in our study may thus show sample
characteristics different to samples in other studies of de-
pression treatments.
With regard to long-term effectiveness, we must point out
that our results should be interpreted with caution due to the
number of patients in the MDT-DH group who completed
post-assessment, yet did not complete follow-up 8 months
later. It should be noted that MDT-DH patients who stopped
participation during the study tended to have higher BDI-II
baseline scores. Therefore, it cannot be ruled out that selective
responding had some influence on our results. Even though
we conducted statistical analyses to check for systematic dif-
ferences between patients with complete data sets and those
who did not complete post assessment, it is still possible that
between end-of-treatment and the final follow-up, the more
stressed or less improved patients stopped participating, while
the more motivated and highly improved patients completed
the study. This could have led to more positive and sustained
results at follow-up. It may be, therefore, that the treatment
concept was more successful in this study than it would have
been had the more depressed patients been included. Further
studies are necessary to determine the effectiveness of MDT-
DH in other patient groups and to more rigorously test the
long-term effectiveness of the programme. Furthermore, even
though the diagnostic eligibility was verified by a structured
interview, the effectiveness of MDT-DH was only assessed
with self-report measures of depression, mindfulness and
work ability. In future studies, we recommend to include
rater-based assessments of depressive symptoms.
Despite the foregoing, it should be noted that the naturalis-
tic setting yields findings with high external validity. The re-
alisation of MDT-DH within the psychiatric clinic was, how-
ever, facilitated by a number of factors, e.g., the use of trained
clinicians with personal mindfulness experience who devel-
oped and upheld the pillars of the treatment concept, which
might not be easy to realise in other day hospitals. Future
research should include checks for adherence and competency
to investigate the impact of therapist variables. Moreover, if
the treatment were to be implemented in other day hospitals, it
could be useful to investigate facilitating and hindering imple-
mentation factors. In addition, patients were encouraged to
engage in mindfulness practice by giving them homework
(e.g., several minutes of meditation per day slowly increasing
over time), but were not monitored for compliance. Future
research should monitor for patients adherence to homework
assignments.
In summary, this randomised controlled pilot study
showed that an intensive eight-week mindfulness-based
treatment concept can be effectively established in a day
hospital setting and is efficacious in reducing depression
severity under routine clinical conditions. We propose that
a day hospital treatment has several important advantages:
the high treatment dose and the possibility to promote
transfer from in-hospital experiences to daily life. Our
findings provide preliminary evidence that MDT-DH can
be a valuable treatment option for patients suffering from
current depression, where this was developed or main-
tained in the context of work-related factors and who are
in need of intensive treatment.
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